Burge MR, Garcia N, Qualls CR, Schade DS
Although it seems to be a perfect model for PD studies, there are criticisms that the rotenone-induced PD model is difficult to reproduce and likely to cause mortality (Hglinger et al., 2003
Potential benefits may include: Support for healthy blood vessel function Improvements in certain cardiovascular risk factors Reduced risk of major cardiovascular events in specific patient populations The exact benefits vary based on individual health conditions and medical history
The 24-29% weight reduction seen with retatrutide at 12mg represents a 50-70% improvement over semaglutide efficacy, depending on the specific semaglutide dose and study population being compared
Clinical and observational studies tentatively confirm these findings, especially among people with concomitant obesity or insulin resistance [83]
doi: 10.3389/fonc.2022.961637 316 ChengXPengTChuTYangYLiuJGaoQet al